NEW YORK (GenomeWeb News) - Thermo Fisher Scientific said today that it has acquired Open Biosystems, a privately held provider of RNAi research products, for an undisclosed sum.
 
Thermo Fisher said in a statement that the acquisition "significantly expands" its presence in the RNAi field because Open Biosystems' specialty, short-hairpin RNA, complements the small-interfering RNA technology it already sells through its Thermo Scientific Dharmacon product line.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.